Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities, calculated as total liabilities divided by total asset. Shanghai INT Medical Instruments Co's Total Liabilities for the quarter that ended in Dec. 2023 was HK$384.2 Mil. Shanghai INT Medical Instruments Co's Total Assets for the quarter that ended in Dec. 2023 was HK$2,220.0 Mil.
Therefore, Shanghai INT Medical Instruments Co's Liabilities-to-Assets Ratio for the quarter that ended in Dec. 2023 was 0.17.
Shanghai INT Medical Instruments Co Liabilities-to-Assets Historical Data
The historical data trend for Shanghai INT Medical Instruments Co's Liabilities-to-Assets can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Shanghai INT Medical Instruments Co's Liabilities-to-Assets, along with its competitors' market caps and Liabilities-to-Assets data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shanghai INT Medical Instruments Co Liabilities-to-Assets Distribution
For the Medical Devices & Instruments industry and Healthcare sector, Shanghai INT Medical Instruments Co's Liabilities-to-Assets distribution charts can be found below:
* The bar in red indicates where Shanghai INT Medical Instruments Co's Liabilities-to-Assets falls into.
Shanghai INT Medical Instruments Co Liabilities-to-Assets Calculation
Liabilities-to-Assets ratio measures the portion of the total liabilities to the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Liabilities-to-Assets ratio is calculated by dividing total liabilities by total asset.
Shanghai INT Medical Instruments Co's Liabilities-to-Assets Ratio for the fiscal year that ended in Dec. 2023 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai INT Medical Instruments Co (HKSE:01501) Liabilities-to-Assets Explanation
Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities. It can vary greatly across different industries, as they have different capital structure. A high Liabilities-to-Assets ratio (more leveraged) suggests that the company might have potential solvency problems, or even a signal of financial distress. Conversely, a low Liabilities-to-Assets ratio usually indicates a healthy financial situation. However, it may also suggest that the company is not expanding or not making good use of debt.
Shanghai INT Medical Instruments Co Liabilities-to-Assets Related Terms
Thank you for viewing the detailed overview of Shanghai INT Medical Instruments Co's Liabilities-to-Assets provided by GuruFocus.com. Please click on the following links to see related term pages.
Shanghai INT Medical Instruments Co (HKSE:01501) Business Description
Shanghai INT Medical Instruments Co Ltd formerly Shanghai Kindly Medical Instruments Co Ltd is a manufacturer of cardiovascular interventional devices, which are mainly used in cardiovascular surgeries, and in particular, PCI procedures in China. It is engaged in the sales, manufacture, research, and development of cardiovascular interventional medical devices as well as related accessories and molds. It is also engaged in the research and development of other interventional and implantable medical devices, such as neurological interventional medical devices and endocardia implantable medical devices, among others. Geographically, it has operations in Mainland China, Europe, the United States, and Other countries.
Shanghai INT Medical Instruments Co (HKSE:01501) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:01501 has been successfully added to your 